tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sam Slutsky, 5 are a BUY (100%).
Analyst Sam Slutsky, currently employed at LIFESCI, carries an average stock price target met ratio of 60% that have a potential upside of 74.43% achieved within 197 days.
Sam Slutsky’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IMVT, Immunovant at 29-Sep-2025.
Analyst best performing recommendations are on IMVT (IMMUNOVANT).
The best stock recommendation documented was for IMVT (IMMUNOVANT) at 3/28/2023. The price target of $31 was fulfilled within 182 days with a profit of $15.5 (100%) receiving and performance score of 5.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Nov-2021
$14
$30
9 months ago
(08-Jan-2026)
3/3 (100%)
$0.16 (1.16%)
161
Buy Since 31-Mar-2022
$14
$14
9 months ago
(08-Jan-2026)
4/6 (66.67%)
$0.16 (1.16%)
105
Buy Since 06-Jun-2024
$14
9 months ago
(08-Jan-2026)
4/10 (40%)
$7.56 (117.39%)
303
Buy Since 12-Aug-2024
$14
$14
9 months ago
(08-Jan-2026)
3/4 (75%)
$0.16 (1.16%)
69
Buy Since 08-Jan-2026
$14
9 months ago
(08-Jan-2026)
8/14 (57.14%)
$0.16 (1.16%)
324
What Year was the first public recommendation made by Sam Slutsky?
